Junxia Feng Selected Research

Proteins (Proteins, Gene)

8/2023	Exosomal PPARγ derived from macrophages suppresses LPS-induced peritonitis by negative regulation of CD14/TLR4 axis.
3/2016	hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junxia Feng Research Topics

Disease

8	Infections 08/2023 - 01/2019
5	Inflammation (Inflammations) 01/2023 - 01/2018
4	Pneumonia (Pneumonitis) 08/2023 - 01/2022
4	Non-alcoholic Fatty Liver Disease 05/2023 - 01/2023
2	Fibrosis (Cirrhosis) 01/2024 - 01/2018
2	Peritonitis 08/2023 - 01/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2018
2	Q Fever (Fever, Q) 01/2019 - 01/2019
1	Communicable Diseases (Infectious Diseases) 12/2024
1	Chronic Renal Insufficiency 01/2024
1	Ureteral Obstruction 01/2024
1	Salmonella Infections (Salmonellosis) 08/2023
1	Sepsis (Septicemia) 06/2023
1	Fatty Liver 01/2023
1	Dysbiosis 01/2023
1	COVID-19 01/2023
1	Ischemia 08/2022
1	Peritoneal Fibrosis 07/2022
1	Liver Abscess 01/2022
1	Kidney Diseases (Kidney Disease) 08/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Plague (Bubonic Plague) 01/2020
1	Reperfusion Injury 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Neoplasms (Cancer) 03/2016

Drug/Important Bio-Agent (IBA)

4	LipopolysaccharidesIBA 08/2023 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 01/2023
3	LipidsIBA 08/2023 - 01/2023
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
2	16S Ribosomal RNAIBA 12/2024 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 08/2023 - 03/2016
2	Virulence Factors (Pathogenicity Factors)IBA 06/2023 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 12/2020
2	Rosiglitazone (Avandia)FDA Link 07/2022 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2021 - 01/2018
2	VaccinesIBA 01/2020 - 01/2019
2	AerosolsIBA 01/2019 - 01/2019
1	CateninsIBA 01/2024
1	capsular-polysaccharide galactohydrolaseIBA 08/2023
1	PPAR gammaIBA 08/2023
1	Ethanol (Ethyl Alcohol)IBA 05/2023
1	CytokinesIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	CarbonIBA 01/2023
1	Polymyxins (Polymyxin)IBA 01/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2023
1	astragaloside AIBA 08/2022
1	Dialysis SolutionsIBA 07/2022
1	2-chloro-5-nitrobenzanilideIBA 07/2022
1	15-deoxyprostaglandin J2IBA 07/2022
1	salmochelinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2021
1	GelsolinIBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	InflammasomesIBA 12/2020
1	Attenuated VaccinesIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	Chloroform (Trichloromethane)IBA 01/2019
1	Methanol (Carbinol)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2018
1	Caspase 9IBA 01/2018
1	Dual Specificity Phosphatase 1IBA 01/2018
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 03/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2016
1	UbiquitinIBA 03/2016

Therapy/Procedure

2	Phage Therapy 01/2023 - 10/2022
2	Therapeutics 10/2022 - 08/2021
2	Peritoneal Dialysis 07/2022 - 01/2018
1	Lasers (Laser) 08/2023